{"id":"W3035357525","doi":"10.2337/db20-28-or","title":"28-OR: How Early after Treatment Initiation Are the CV Benefits of Empagliflozin Apparent? A Post Hoc Analysis of EMPA-REG OUTCOME","year":2020,"lang":"en","type":"article","venue":"Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Empagliflozin; Medicine; Hazard ratio; Placebo; Internal medicine; Post-hoc analysis; Type 2 diabetes; EMPA; Proportional hazards model; Cumulative incidence; Diabetes mellitus; Endocrinology; Confidence interval; Pathology; Cohort","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006596933,0.00161726,0.004936215,0.0003419617,0.0001933081,0.001474305,0.0007897324,0.001074822,0.006187974],"category_scores_gemma":[0.006018892,0.0003384374,0.007210485,0.0003289469,0.0005287845,0.001420543,0.0006142245,0.00284183,0.0008927201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003940265,"about_ca_system_score_gemma":0.0005800826,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006953146,"about_ca_topic_score_gemma":0.0009954268,"domain_scores_codex":[0.9960521,0.002645625,0.0001390029,0.0005318053,0.0002307275,0.0004007644],"domain_scores_gemma":[0.9973109,0.001625985,0.0004095604,0.0003167205,0.0001424068,0.0001944775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9216281,0.001065215,0.01145462,0.001663258,0.01331046,0.0001322467,0.00007519109,0.002494624,0.003315589,0.000603356,0.00340031,0.04085716],"study_design_scores_gemma":[0.3984974,0.1916949,0.2476325,0.0008431865,0.08462138,0.0006446108,0.0003441678,0.03154036,0.0141714,0.007933171,0.02175535,0.0003216028],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9680982,0.009255739,0.007141041,0.00145846,0.0007778523,0.001015116,0.005901917,0.0003536427,0.005998024],"genre_scores_gemma":[0.9865718,0.001284967,0.00221604,0.0007409914,0.0004134241,0.001022004,0.00245588,0.0001010581,0.005193993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006596933,"threshold_uncertainty_score":0.03488839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03751761026768973,"score_gpt":0.2624780422234293,"score_spread":0.2249604319557396,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}